Skúsiť demo Otvoriť účet
Obchodovanie
CFD
Binárne Opcie
Krypto
Banko­vníctvo
B2B
Trhové Informácie
O Dukascopy
Skúsiť demo Otvoriť účet

GSK wins rights to Merck's immunotherapy

Note: This section contains information in English only.
Source: Dukascopy Bank SA
GlaxoSmithKline has boosted its pipeline for cancer drug development on Tuesday and agreed to pay about $4.22B to the German firm Merck KgaA for its rights to immunotherapy.
Back to articles

Actual Topics

05 Feb 2019

TIM auditors unable to meet Vivendi request on meeting

Telecom Italia auditors stated they were unable to comply with the major investor Vivendi's request for holding the shareholder meeting potentially planned for this month with the aim to replace five members of the board.

05 Feb 2019

GM to add 1K jobs to Michigan's Flint pickup truck plant

On Tuesday, General Motors announced it would add 1K new workers to establish heavy-duty pick-up trucks at the company's plant in Michigan, giving the priority to the ex-GM employees.

05 Feb 2019

T-Mobile vows to halt price growth if merger approved

On Tuesday, the T-Mobile US announced it would halt the price growth for three years, including some exceptions, if it received an approval to acquire its competitor Sprint Corp in a deal worth $26B.